|
US20020072509A1
(en)
*
|
2000-10-11 |
2002-06-13 |
Stein Donald Gerald |
Methods for the treatment of a traumatic central nervous system injury
|
|
SE0104423D0
(sv)
|
2001-12-27 |
2001-12-27 |
Umecrine Ab |
Pregnane steroids and their use in the treatment of CNS disorders
|
|
DK1812009T3
(da)
*
|
2004-11-18 |
2013-08-05 |
Umecrine Ab |
GABA-steroidantagonister og deres anvendelse til behandling af CNS-lidelser
|
|
RU2413516C2
(ru)
*
|
2004-11-18 |
2011-03-10 |
Умекрин Аб |
Гамк-стероидные антагонисты и их применение в лечении нарушений цнс
|
|
DE102006003508A1
(de)
*
|
2006-01-24 |
2007-07-26 |
Grünenthal GmbH |
Arzneimittel umfassend eine Hormonkombination
|
|
DE102006003509A1
(de)
*
|
2006-01-24 |
2007-07-26 |
Grünenthal GmbH |
Kontrazeptivum
|
|
US20070203216A1
(en)
*
|
2006-02-14 |
2007-08-30 |
Bjarke Ebert |
Method of treating inflammatory diseases
|
|
EP2711372A1
(en)
|
2006-11-21 |
2014-03-26 |
Umecrine AB |
The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of CNS disorders
|
|
EP2167098B1
(en)
*
|
2007-06-11 |
2018-09-05 |
University Of Southern California |
Allopregnanolone in a method for enhancing neurological function (alzheimer disease)
|
|
US20100204192A1
(en)
|
2007-06-11 |
2010-08-12 |
University Of Sourthern California |
Agents, compositions and methods for enhancing neurological function
|
|
US20090048288A1
(en)
*
|
2007-08-13 |
2009-02-19 |
H. Lundbeck A/S |
Method of treating stress-mediated depression
|
|
JP5687287B2
(ja)
*
|
2010-01-14 |
2015-03-18 |
ウメクライン ムード エービー |
改善された保存性及び溶解特性を有する3−ベータ−ヒドロキシ−5−アルファ−プレグナン−20−オンを含有する薬学的組成物
|
|
CN106983754A
(zh)
|
2011-05-20 |
2017-07-28 |
国家医疗保健研究所 |
Cb1受体拮抗剂
|
|
US10478505B2
(en)
|
2011-09-23 |
2019-11-19 |
The Regents Of The University Of California |
Edible oils to enhance delivery of orally administered steroids
|
|
SG10201606063RA
(en)
|
2012-01-23 |
2016-09-29 |
Sage Therapeutics Inc |
Neuroactive steroid formulations and methods of treating cns disorders
|
|
WO2014028398A2
(en)
|
2012-08-13 |
2014-02-20 |
The Regents Of The University Of California |
Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
|
|
RS62761B1
(sr)
|
2012-08-21 |
2022-01-31 |
Sage Therapeutics Inc |
Alopregnanolon za lečenje refraktornog epileptičkog statusa
|
|
RU2667065C2
(ru)
|
2012-11-28 |
2018-09-14 |
Энсэрм (Энститю Насьональ Де Ля Санте Э Де Ля Решерш Медикаль) |
Производные прегненолона
|
|
US20150313915A1
(en)
*
|
2012-11-30 |
2015-11-05 |
The Regents Of The University Of California |
Anticonvulsant activity of steroids
|
|
CN106163528A
(zh)
|
2014-01-29 |
2016-11-23 |
梅克芳识别有限公司 |
用于治疗肝脑病的甾族化合物
|
|
JOP20200195A1
(ar)
|
2014-09-08 |
2017-06-16 |
Sage Therapeutics Inc |
سترويدات وتركيبات نشطة عصبياً، واستخداماتها
|
|
WO2016082789A1
(en)
*
|
2014-11-27 |
2016-06-02 |
Sage Therapeutics, Inc. |
Compositions and methods for treating cns disorders
|
|
TWI748936B
(zh)
|
2015-01-12 |
2021-12-11 |
瑞典商優鎂奎認知Ab公司 |
新穎化合物
|
|
PH12018501923B1
(en)
|
2016-03-08 |
2024-06-28 |
Sage Therapeutics Inc |
Neuroactive steroids, compositions, and uses thereof
|
|
US10278977B2
(en)
|
2016-06-06 |
2019-05-07 |
Umecrine Cognition Ab |
Methods for treating hypersomnolence
|
|
US10933014B2
(en)
|
2017-01-09 |
2021-03-02 |
Asarina Pharma Ab |
Injectable suspension comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, and a method for the manufacturing thereof
|
|
CN110430883A
(zh)
|
2017-02-10 |
2019-11-08 |
阿沙里那制药公司 |
用于医学治疗的3β-羟基-5α-孕烷-20-酮
|
|
WO2018147791A1
(en)
|
2017-02-10 |
2018-08-16 |
Asarina Pharma Ab |
3-beta-hydroxy-5-alpha-pregnan-20-one for use in treatment of essential tremor
|
|
US20210228596A1
(en)
*
|
2017-10-12 |
2021-07-29 |
Sage Therapeutics, Inc. |
Method of treating cns disorders with neurosteroids and gabaergic compounds
|
|
CN111918657A
(zh)
|
2018-04-05 |
2020-11-10 |
阿沙里那制药有限公司 |
用于治疗物质戒断障碍的gaba-a拮抗剂
|
|
US20240383942A1
(en)
|
2021-09-14 |
2024-11-21 |
Nanjing Minova Pharmaceutical Co., Ltd. |
Water-soluble allopregnanolone derivative, and preparation method therefor and use thereof
|
|
WO2023083980A1
(en)
|
2021-11-10 |
2023-05-19 |
Umecrine Ab |
Steroid as a modulator of gabaa receptor
|
|
WO2023083978A1
(en)
|
2021-11-10 |
2023-05-19 |
Umecrine Ab |
3.alpha.-substituted 3.beta.-hydroxy 17-oximated androstane compound for modulation of the alpha-3 subtype of the gaba-a receptor
|
|
WO2023083979A1
(en)
|
2021-11-10 |
2023-05-19 |
Umecrine Ab |
3.beta.-hydroxy, 3.alpha.-ethyl steroids for modulation of the alpha-3 subtype of the gaba-a receptor
|